Systemic sclerosis (SSc) has heterogeneous symptoms and significant medical morbidity. Recently, itch was described as a symptom of SSc (prevalence of 42,6%). To the investigators knowledge, no study yet has examined the clinical features of itch neither had used a specific itch-related quality of life (QoL) scales in patients with SSc. The objectives were to evaluate the prevalence of pruritus, its characteristics and its impact on the QoL in those patients. In this descriptive study, patients followed for SSc in the departments of dermatology, rheumatology, internal medicine and pulmonology at the University Hospital of Brest were included. Participants received a questionnaire including questions about the clinical features of pruritus and 2 scores (5-D itch scale, ItchyQol).
Study Type
OBSERVATIONAL
Enrollment
61
CHRU de Brest
Brest, France
Pruritus
Pruritus: yes/no
Time frame: Day 1 (questionnaire sent to patient)
Characteristics of the systemic sclerosis
Duration of the disease
Time frame: Day 1 (questionnaire sent to patient)
Brest questionnaire
questions about the chronology, location, intensity, disruption of daily activities, characteristics of scratching and other associated sensations
Time frame: Day 1 (questionnaire sent to patient)
5-D itch scale
Validated questionnaire about severity of pruritus using five items (duration, intensity, evolution, impact on daily activities, localisation)
Time frame: Day 1 (questionnaire sent to patient)
ItchyQol scale
questionnaire about quality of life linked to pruritus
Time frame: Day 1 (questionnaire sent to patient)
Characteristics of the systemic sclerosis
treatments,
Time frame: Day 1 (questionnaire sent to patient)
Characteristics of the systemic sclerosis
topography of skin involvement (limited or diffuse systemic sclerosis)
Time frame: Day 1 (questionnaire sent to patient)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.